PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pharma payment rankings

Six source-bounded views of reported General Payments to U.S. health care providers. A payment is a disclosed financial relationship, not evidence of wrongdoing.

6
distinct leaderboards
1,925
companies in the payment corpus
$13.9B
reported General Payments
24%
held by the top five companies shown

The payment picture

Novartis Pharmaceuticals Corporation leads the company table at $676.0M, while California has the largest state total at $342.4M.

$676.0M
Novartis Pharmaceuticals Corporation, largest company total
$342.4M
California, largest state total
23.6%
of the reported total in the five-company preview
PY2024
latest CMS program year used here

The leaderboards describe reported payments. They do not measure prescribing, clinical quality, or misconduct.

Largest reported company payment totals

1. Novartis Pharmaceuticals …$676.0M2. PFIZER INC.$673.7M3. ModernaTX, Inc.$665.3M4. Eli Lilly and Company$652.4M5. ABBVIE INC.$607.8M
Top five company totals in CMS Open Payments Program Year 2024. The full table distinguishes reported payment volume from company revenue.

Browse by question

Choose the measure that answers your question

Company and state totals show volume. Per-physician figures adjust for the number of physician recipients. Recipient lists show disclosed totals, not a judgment about the people named.

Top Recipient Physicians

Individual physicians who received the largest total payments from pharma companies.

Open list →
  1. 1 CHARLES GOODIS $91.1M
  2. 2 ROBERT MEDOFF $26.7M
  3. 3 CHARLES DECOOK $26.2M
  4. 4 ANDREW COOPER $25.3M
  5. 5 NITIN GOYAL $25.0M

Top Recipient Hospitals

Teaching hospitals that received the largest total payments from pharma companies.

Open list →
  1. 1 Hospital Of The Univ Of Penna $190.0M
  2. 2 Dana-farber Cancer Institute $72.6M
  3. 3 Univ Of Missouri Health Care $64.8M
  4. 4 Massachusetts General Hospital $40.0M
  5. 5 Univ Of Mi Hospitals & Hlth Ctrs $26.7M

How to read the rankings

CMS requires applicable manufacturers and group purchasing organizations to report transfers of value. PlainPharmaWatch groups the current annual release by reporting company, recipient state, recipient, and payment category so each table can be checked against its detail pages.

Totals do not show whether a payment affected patient care or prescribing. High recipient totals can reflect research, royalties, clinical-trial work, speaking, travel, or other reported activity. Read the CMS context and the methodology before drawing conclusions about a person or organization.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.